CDKN2A and Familial prostate cancer: GE can reverse DNA hypermethylation and reactivates p16INK4a, RARb and MGMT in KYSE 510 esophageal squamous cell carcinoma cells, KYSE 150 cells, prostate cancer LNCaP and PC3 cells (Fang et al., 2005).